HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory Verhoest Selected Research

Necrosis

2/2015Identification and validation of TGFBI as a promising prognosis marker of clear cell renal cell carcinoma.
8/2014Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory Verhoest Research Topics

Disease

13Neoplasms (Cancer)
02/2023 - 04/2008
12Renal Cell Carcinoma (Grawitz Tumor)
04/2021 - 04/2008
5Carcinoma (Carcinomatosis)
02/2023 - 04/2008
4Neoplasm Metastasis (Metastasis)
06/2022 - 01/2008
3Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 11/2018
2Proteinuria
04/2015 - 02/2014
2Hypertension (High Blood Pressure)
04/2015 - 02/2014
2Carcinogenesis
02/2015 - 08/2014
2Necrosis
02/2015 - 08/2014
1Non-Muscle Invasive Bladder Neoplasms
09/2023
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2023
1Vascular System Injuries
09/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2023
1Tuberous Sclerosis (Bourneville's Disease)
04/2021
1Peritoneal Neoplasms
06/2018
1Chronic Renal Insufficiency
04/2017
1Solitary Kidney
04/2017
1Ischemia
01/2015
1Pre-Eclampsia (Preeclampsia)
02/2014

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
10/2019 - 08/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 04/2008
2Biomarkers (Surrogate Marker)IBA
04/2020 - 02/2015
2B7-H1 AntigenIBA
04/2020 - 01/2017
2Sunitinib (Sutent)FDA Link
01/2019 - 10/2017
1AntibodiesIBA
11/2021
1trans-sodium crocetinate (crocetin)IBA
04/2021
1Immune Checkpoint InhibitorsIBA
04/2019
1LigandsIBA
04/2019
1Death Domain ReceptorsIBA
04/2019
1Tyrosine Kinase InhibitorsIBA
10/2017
14- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA
04/2015
1Indicators and Reagents (Reagents)IBA
02/2015
1chloropentaamminerhodium(III)IBA
08/2014
1CreatinineIBA
02/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2008
1Sirolimus (Rapamycin)FDA Link
04/2008
1Interferon-alpha (Interferon Alfa)IBA
04/2008
1Interleukin-2 (IL2)IBA
04/2008

Therapy/Procedure

9Nephrectomy
10/2018 - 01/2008
8Therapeutics
06/2022 - 04/2008
6Cystectomy
09/2023 - 11/2018
3Urinary Diversion (Ileal Conduit)
09/2023 - 11/2018
2Kidney Transplantation
01/2023 - 01/2020
2Immunotherapy
04/2020 - 04/2008
1Length of Stay
09/2023
1Drug Therapy (Chemotherapy)
09/2023
1Lymph Node Excision (Lymph Node Dissection)
09/2023
1Conversion to Open Surgery
09/2023
1Blood Transfusion (Blood Transfusions)
02/2023
1Radiotherapy
01/2023
1Neoadjuvant Therapy
07/2022
1Nephroureterectomy
01/2022
1Transplantation
01/2020
1Radiofrequency Ablation
04/2017
1Cryosurgery
04/2017
1Warm Ischemia
01/2015